References
Hughes WT, Armstrong D, Bodey G, and the IDSA Working Group 1990: Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Journal of Infectious Diseases, 161: 381–396.
Pizzo P: Management of fever in patients with cancer and treatment-induced neutropenia. New England Journal of Medicine 1993, 328: 1323–1332.
Ramphal R, Bolger M, Oblohn DJ: Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime. Antimicrobial Agents and Chemotherapy 1992, 36: 1062–1067.
Viscoli C, Van Der Auwera P, Meunier F: Gram positive infections in granulocytopenic patients. Journal of Antimicrobial Agents and Chemotherapy 1988, 21: 149–156.
Urbaskova J: Antibiotic resistance surveillance in Czechoslovakia in 1990–1993. State Institute of Public Health, Prague, 1994, p. 55.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Krcmery, V., Trupl, J., Drgona, L. et al. Nosocomial bacteremia due to vancomycin-resistantStaphylococcus epidermidis in four patients with cancer, neutropenia, and previous treatment with vancomycin. Eur. J. Clin. Microbiol. Infect. Dis. 15, 259–261 (1996). https://doi.org/10.1007/BF01591369
Issue Date:
DOI: https://doi.org/10.1007/BF01591369